Listed Funds Trust has filed a certification under Rule 497(j) with the U.S. Securities and Exchange Commission (SEC) regarding its prospectus for the Spear Alpha ETF. This certification indicates that the form of Prospectus and Statement of Additional Information that would have been filed does not differ from the version contained in the recent Post-Effective Amendment to the Trust’s Registration Statement.
This filing, dated October 30, 2026, is significant as it reflects the Trust's commitment to regulatory compliance and transparency in its operations. The Spear Alpha ETF, which is part of Listed Funds Trust, continues to align with the requirements set forth by the SEC, ensuring that investors have access to accurate and timely information.
Background
Listed Funds Trust is an investment company based in Milwaukee, Wisconsin. The company operates under the Central Index Key (CIK) number 0001683471 and has been active in the investment sector. Its recent filings include various forms related to the management and registration of its investment products, including the Spear Alpha ETF.
What the Filing Says
The filing states, "Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, the Trust on behalf of Spear Alpha ETF, hereby certifies that the form of Prospectus and Statement of Additional Information that would have been filed under Rule 497(b) or (c) would not have differed from that contained in the Post-Effective Amendment No. 634 to the Trust’s Registration Statement on Form N-1A effective on October 31, 2026 and filed on October 23, 2026." This indicates that there are no changes to the previously filed documents.
Impact
This update may affect investors and stakeholders in the Spear Alpha ETF, as it assures them of the consistency and reliability of the information provided. It also highlights the importance of regulatory compliance in the investment industry, where transparency is crucial for maintaining investor trust.
What's Next
The filing does not say what happens next.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






